Isioma U. Egbuniwe
Nottingham, ENG NG72RD, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
The role of mesenchymal cells in cholangiocarcinoma.
Journal: Disease models & mechanisms
Published: January 28, 2024
Targeting alternative splicing as a new cancer immunotherapy-phosphorylation of serine arginine-rich splicing factor (SRSF1) by SR protein kinase 1 (SRPK1) regulates alternative splicing of PD1 to generate a soluble antagonistic isoform that prevents T cell exhaustion.
Journal: Cancer immunology, immunotherapy : CII
Published: June 07, 2023
Effect of Combining EGFR Tyrosine Kinase Inhibitors and Cytotoxic Agents on Cholangiocarcinoma Cells.
Journal: Cancer research and treatment
Published: June 17, 2020
B Lymphocytes Accumulate and Proliferate in Human Skin at Sites of Cutaneous Antigen Challenge.
Journal: The Journal of investigative dermatology
Published: May 09, 2020
Breast Tumours Resembling the Tall Cell Variant of Thyroid Papillary Carcinoma: Are They Part of the Papillary Carcinoma Spectrum or a Distinct Entity?
Journal: Pathobiology : journal of immunopathology, molecular and cellular biology
Published: April 09, 2018
IgG subclass switching and clonal expansion in cutaneous melanoma and normal skin.
Journal: Scientific reports
Published: May 13, 2016
Elevated IgG4 in patient circulation is associated with the risk of disease progression in melanoma.
Elevated IgG4 in patient circulation is associated with the risk of disease progression in melanoma.
Journal: Oncoimmunology
Published: February 27, 2015
Effects of BRAF mutations and BRAF inhibition on immune responses to melanoma.
Journal: Molecular cancer therapeutics
Published: November 12, 2014
Revisiting the role of B cells in skin immune surveillance.
Journal: Trends in immunology
Published: September 16, 2014
Showing 1-10 of 10
Last Updated: 09/26/2026